» Authors » Saulo Purisch

Saulo Purisch

Explore the profile of Saulo Purisch including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 57
Citations 303
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosario P, Purisch S
Arq Bras Endocrinol Metabol . 2010 Sep; 54(6):546-9. PMID: 20857059
Objective: To evaluate the frequency of subclinical acromegaly (in the absence of clinical phenotype but biochemically uncontrolled) in patients with prolactinoma during treatment with dopaminergic agonists. Subjects And Methods: One...
2.
3.
Rosario P, Purisch S
Gynecol Endocrinol . 2010 May; 27(3):205-8. PMID: 20504103
Objective: To evaluate the frequency of elevated TSH in pregnant women of low risk for thyroid dysfunction. Subjects And Methods: TSH was measured in 838 pregnant women during the first...
4.
Rosario P, Salles D, Bessa B, Purisch S
Arq Bras Endocrinol Metabol . 2010 Apr; 54(1):56-9. PMID: 20414549
Objective: To evaluate the contribution of (131)I scintigraphy and ultrasonography to the prediction of malignancy in thyroid nodules with indeterminate cytology in euthyroid patients. Subjects And Methods: The sample consisted...
5.
Rosario P, Purisch S
Arq Bras Endocrinol Metabol . 2010 Apr; 54(1):52-5. PMID: 20414548
Objective: To report the results of repeat fine-needle aspiration cytology (FNAC) in thyroid nodules with an initial benign cytological diagnosis that grow during follow-up and/or present suspicious ultrasonographic characteristics. Subjects...
6.
Rosario P, Salles D, Bessa B, Purisch S
Arq Bras Endocrinol Metabol . 2010 Feb; 53(9):1143-5. PMID: 20126872
Objective: To report the results of cytology and histology obtained for a series of systematically resected thyroid nodules >or= 4 cm. Methods: A group of 151 patients with thyroid nodules...
7.
Rosario P, Salles D, Purisch S
Arq Bras Endocrinol Metabol . 2009 Nov; 53(6):767-70. PMID: 19893921
Objective: The levothyroxine withdrawal (L-T4) for some weeks results in prolonged exposure to elevated TSH. In contrast, administration of recombinant human TSH (rhTSH) promotes a short period of hyperthyrotropinemia. The...
8.
Romualdo-Silva D, Silva B, Caetano C, Tiburcio A, Nunes M, Chagas S, et al.
Arq Bras Endocrinol Metabol . 2009 Jul; 53(3):378-82. PMID: 19578602
Tumor-induced osteomalacia (TIO) is a rare paraneoplasic syndrome with overproduction of fibroblast growth factor 23 as a phosphaturic agent, leading to chronic hyperphosphaturia and hypophosphatemia, associated with inappropriately normal or...
9.
Rosario P, Bessa B, Valadao M, Purisch S
Thyroid . 2008 Nov; 19(1):9-12. PMID: 19021461
Background: Clinical repercussions, progression to overt hypothyroidism, and treatment benefits have been well established in patients with subclinical hypothyroidism (SCH) and TSH >10 mIU/L. In contrast, these aspects of the...
10.
Rosario P, Vasconcelos F, Purisch S
Endocr Pract . 2008 Nov; 14(7):948-9. PMID: 19004135
No abstract available.